Last modified: 31 May 2022 13:05
The course will focus on small molecule drug discovery. Receptor theory and cell communication and signalling will be revised to facilitate understanding of the remainder of the course. The basis of the drug discovery process will be described and the phases of drug development discussed. A range of targets for drug discovery will be identified and how small molecule drug affect these will be described. Issues around drug regulation will be raised.
|Session||First Sub Session||Credit Points||15 credits (7.5 ECTS credits)|
This applied course will cover the latest developments in small molecule drug discovery and development. The course will progress logically through the process of identifying and characterising lead drug candidates to the point when they enter clinical trials. Much of the course will focus on the two main areas:
The second component of the course will cover in detail the steps taken to minimise any unwanted side effects in drugs used for therapy. Wherever possible the course will use real clinical examples to deliver its applied message effectively and clearly. The course will also include presentations from industry professionals.
Information on contact teaching time is available from the course guide.
2x 25% Online Oral Exam
25% Individual Poster
25% Individual Presentation
Alternative Resit Assessment
30 minute oral exam examining all ILOs. Two examiners would be present.
There are no assessments for this course.
|Knowledge Level||Thinking Skill||Outcome|
|Conceptual||Understand||To demonstrate understanding of the different phases of drug discovery and the key processes run through each phase.|
|Procedural||Create||To be able to deduce and identify what should be considered in designing a new drug against a specific target.|
|Procedural||Apply||To be able to identify druggable targets.|